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Transcriptome analysis reveals differences
in mechanisms regulating cessation of
luteal function in pregnant and non-
pregnant dogs
Sophie Zatta1, Hubert Rehrauer2, Aykut Gram1, Alois Boos1 and Mariusz Pawel Kowalewski1*
Abstract
Background: In the domestic dog, corpora lutea (CL) are the only source of progesterone (P4), both in pregnant
and non-pregnant cycles because there is no placental steroidogenesis. The absence of an endogenous luteolysin
in absence of pregnancy results in long-lasting physiological pseudopregnancy, strongly contrasting with the acute
luteolysis observed prepartum. The underlying biological mechanisms and the involvement of P4 signalling remain,
however, not fully understood. Therefore, here, next-generation sequencing (RNA-Seq) was performed on CL from
the late luteal phase and compared with normally luteolyzing CL collected at the prepartum P4 decrease.
Results: The contrast “luteal regression over luteolysis” yielded 1595 differentially expressed genes (DEG). The CL in late
luteal regression were predominantly associated with functional terms linked to extracellular matrix (p = 5.52e-05).
Other terms related to transcriptional activity (p = 2.45e-04), and steroid hormone signalling (p = 2.29e-04), which were
more highly represented in late regression than during luteolysis. The prepartum luteolysis was associated with
immune inflammatory responses (p = 2.87e-14), including acute-phase reaction (p = 4.10e-06). Immune system-related
events were also more highly represented in CL derived from normal luteolysis (p = 7.02e-04), compared with those
from dogs in which luteolysis was induced with an antigestagen (1480 DEG in total). Additionally, the withdrawal of P4
at mid-gestation resulted in 92 DEG; over-represented terms enriched in antigestagen-treated dogs were related to the
inflammatory response (p = 0.005) or response to IL1 (p = 7.29e-05). Terms related to proliferation, e.g., centrosome
organization (p = 0.002) and steroid metabolic processes (p = 0.001), prevailed at mid-gestation. Thereby, our results
revealed the nature of luteotropic effects of P4 within canine CL. It appears that, even though they result in diminished
steroidogenic output, the effect of antigestagens is more related to the withdrawal of P4 support than to the
PGF2alpha-related inflammatory reaction observed at physiological parturition.
Conclusions: We report the differential gene expression associated with maintenance and cessation of luteal function
in pregnant and non-pregnant dogs. Based on the differentially expressed genes, we indicate functional pathways and
gene networks that are potentially involved in the underlying endocrine and molecular mechanisms. This study
establishes future research directions that may be helpful in understanding some of the clinical conditions, such as
luteal insufficiency, associated with negative pregnancy outcome in dogs.
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Background
The domestic dog is classified as a mono-estric, polyto-
cous and aseasonal breeder, with an obligatory quies-
cence phase called anestrus [1, 2]. Although canine
reproduction has already attracted some attention, still
many of the species-specific peculiarities remain not
fully understood. Unlike in livestock, the dog lacks pla-
cental steroidogenesis [3]. Thus, luteal P4 is the only
major source of circulating levels of this hormone, both
in non-pregnant cycles and during pregnancy. The life-
span of corpora lutea (CL) in non-pregnant bitches often
outlasts the luteal duration in pregnant animals [4]. The
luteal phase and P4 levels are almost identical in both
situations until around day 60, i.e., prior to parturition
when a steep decline of serum P4 is observed in preg-
nant dogs, indicating prepartum luteolysis [5, 6]. In con-
trast, in the non-pregnant dog a slow decline of P4 is
observed, until basal levels of P4 reach <1 ng/ml, indi-
cating the onset of anestrus [4, 7]. Moreover, at least in
non-pregnant dogs, the function of CL is independent of
a uterine luteolysin (PGF2alpha), and remains unaffected
by hysterectomy [8]. Also, a luteolytic function of intra-
luteally produced prostaglandins can be ruled out [9]. In
pregnant dogs, the prepartum decline of P4 is concomi-
tant with increased circulating levels of PGF2alpha, pre-
dominantly of fetal placental origin, indicating its role
during parturition and/or luteolysis [3, 5, 6, 10, 11].
During the early luteal phase, canine CL exhibit de-
creased sensitivity to gonadotropic support [12, 13] and
luteal PGE2 seems to be a potent luteotropic factor [14–
16]. The period of relative gonadotropin independence
ends at around day 25 post ovulation (p.o.) [13] and pro-
lactin (PRL) becomes the main luteotropic factor there-
after [17, 18]. However, despite the continuously
increasing availability of PRL and luteinizing hormone
(LH), during the second half of diestrus luteal regression
sets in, associated with structural degeneration of CL
and without any signs of strong apoptosis [2, 19]. Conse-
quently, based on the evidence so far, regression of the
CL in the dog seems to be a passive degenerative process
(reviewed in [1]). Only during prepartum luteolysis are
the acute PGF2alpha surge and the concomitant steep
fall of P4 associated with massive apoptotic activity
within the CL [1]. Interestingly, there is no pregnancy-
and/or parturition-related increase in estrogens in dogs
[3]. The luteotropic role of P4 is substantiated by the
fact that application of an antigestagen induces the
utero-placental signaling cascade, unequivocally result-
ing in preterm luteolysis/abortion [2, 10, 20].
The role of the immune system in canine CL function
is still not fully elucidated. Hoffmann and collaborators
[21] reported the time-dependent presence of CD4- and
CD8-positive immune cells along with cells staining
positively for MHC II complex in the CL tissue of non-
pregnant dogs. Additionally, expression of several inter-
leukins (IL) and cytokines was confirmed at different
stages of development in non-pregnant canine CL [22].
Recently, similar observations have been made with
regards to canine CL of pregnancy [23], implying an ac-
tive involvement of the immune system in the prepar-
tum luteolytic cascade.
Nevertheless, regulatory mechanisms governing the
canine CL lifespan, and especially differences in termin-
ation of CL function in pregnant vs. non-pregnant
bitches, remain not fully understood. Therefore, aiming
to obtain deeper insights into underlying endocrine
regulatory mechanisms, herein, a next-generation deep
RNA sequencing (RNA-Seq) was employed to investigate
global gene expression during the maintenance and ces-
sation of canine CL function. Luteal samples collected at
prepartum luteolysis were compared with corresponding
samples from non-pregnant dogs obtained during late
CL regression (day 65 p.o.). The changes evoked by pre-
partum PGF2alpha release were assessed by comparing
mid-gestation samples with those from active prepartum
luteolysis. Additionally, in order to assess P4-dependent
effects, samples were obtained from bitches in which
pre-term luteolysis/abortion was induced at mid-term by
the antigestagen aglepristone. The global gene expres-
sion in these samples was compared with natural prepar-
tum luteolysis as well as with mid-pregnant dogs.
This is the first comprehensive, comparative transcrip-
tome analysis of canine CL in pregnant and non-pregnant
bitches during cessation of the CL life span, including a
functional approach demonstrating antigestagen-mediated
effects.
Methods
Animals, tissue sampling and preservation
All animal experiments and use of tissue samples were
in accordance with animal welfare legislation and were
approved by the respective authorities of the Justus-
Liebig University, Giessen, Germany (permit no. II 25.3-
19c20-15c GI 18/14 and VIG3-19c-20/15c GI 18,14) and
the University of Ankara (permit no. 2006/06), Ankara,
Turkey. All tissues were used in our previous experi-
ments [24, 25]. Thus, corpora lutea (CL) from clinically
healthy, cross-breed bitches (aged 2–8 years) were used
representing the following experimental groups: (Group-
1) mid-pregnancy (days 35–40 post ovulation, p.o.;
n = 5); (Group-2) active prepartum luteolysis (n = 3);
(Group-3) antigestagen-treated mid-gestation group
(days 40–45 p.o.; n = 5); (Group-4) non-pregnant bitches
at late CL regression (day 65 p.o.; n = 5).
In all dogs the time of ovulation was determined by
measurements of plasma P4 (> 5 ng/ml) and by vaginal
histology [26]. Pregnant dogs were mated 2 days after
ovulation (Day 0), which in the dog is the time needed
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for completion of oocyte maturation within the oviduct.
To determine active prepartum luteolysis (Group-2), P4
concentrations in peripheral blood plasma were mea-
sured at 6 h intervals beginning on day 58 of pregnancy;
when P4 levels in 3 consecutive measurements fell below
2–3 ng/ml, the tissue material was collected. The re-
spective P4 levels are presented in [10]. In Group 3, pre-
partum luteolysis/abortion was induced with the
antigestagen aglepristone (Alizine(R), Virbac, Bad Olde-
sloe, Germany; 10 mg/Kg bw, 2×/24 h apart) and the tis-
sues were collected 24 h after the second application.
All dogs underwent routine ovariohysterectomy. Im-
mediately after surgery, the CL tissues were trimmed of
surrounding ovarian tissue, washed with phosphate-
buffered saline (PBS) and placed in RNAlater(R)
(Ambion Biotechnologie GmbH, Wiesbaden, Germany)
for 24 h at +4 °C, and then stored at −80 °C until use.
Tissues from all animals were used for RNA-Seq and
TaqMan PCR experiments. Because of limited tissue mater-
ial in Group-4, only three of five samples were used for
RNA-Seq. Due to formal restrictions regarding collection of
tissue material and experimental procedures, Group-2 (pre-
partum luteolysis) was comprised of only three replicates.
RNA isolation and purification
Total RNA was extracted using TRIzol(R) Reagent follow-
ing the manufacturer’s protocol (Invitrogen, Carlsbad, CA,
USA). The RNA purity and quantity was measured with a
NanoDrop 2000C(R) spectrophotometer (Thermo Fischer
Scientific AG, Reinach, Switzerland). Further purification
of RNA was performed by the RNeasy® Mini Kit (Qiagen
GmbH, Hilden, Germany). RNA integrity was assessed
with the Agilent 2200 TapeStation System. The RNA in-
tegrity numbers (RIN) ranged from 7.2 to 9.5.
RNA-sequencing and data evaluation
Library preparation
The quality and quantity of isolated RNA were determined
with a Qubit® (1.0) Fluorometer (Life Technologies, Califor-
nia, USA) and a Bioanalyzer 2100 (Agilent, Waldbronn,
Germany). The TruSeq RNA Sample Prep Kit v2 (Illumina,
Inc., California, USA) was used in the succeeding steps.
Briefly, total RNA samples (100-1000 ng) were poly-A
enriched and then reverse-transcribed into double-stranded
cDNA. The cDNA samples were fragmented, end-repaired
and polyadenylated before ligation of TruSeq adapters con-
taining the index for multiplexing. Fragments containing
TruSeq adapters on both ends were selectively enriched
with PCR. The quality and quantity of enriched libraries
were validated using the Qubit(R) (1.0) Fluorometer and
the Caliper GX LabChip(R) GX (Caliper Life Sciences, Inc.,
USA). The product is a smear with an average fragment
size of approximately 260 bp. The libraries were normalized
to 10 nM in Tris-Cl 10 mM, pH 8.5 with 0.1% Tween 20.
Cluster generation and sequencing
The TruSeq PE Cluster Kit v4-cBot-HS or TruSeq SR Clus-
ter Kit v4-cBot-HS (Illumina, Inc., California, USA) were
used for cluster generation using 10 pM of pooled normal-
ized libraries on the cBOT System. Sequencing was per-
formed on the Illumina HiSeq 2500 single end 125 bp
using the TruSeq SBS Kit v4-HS (Illumina, Inc.). The data
described in this publication have been deposited in NCBI’s
Gene Expression Omnibus and are accessible through
GEO Series accession number GSE98657 (https://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=azclmwquv
jwftsl&acc=GSE98657).
Data analysis
For the quantitative assessment of gene expression, next
generation sequencing (NGS, RNA-Seq) was performed.
To align the large transcriptome RNA-Seq dataset, the
Spliced Transcripts Alignment to Reference (STAR-
aligner) software was used to perform RNA-Seq data
read-alignment [27]. As for the reference genome, the
Ensembl genome build CanFam3.1 was used (www.en-
sembl.org/Canis_familiaris/Info/Index). With the func-
tion featureCounts from the R package Rsubread, the
gene expression values were calculated [28]. We consid-
ered a gene as detected if it had an average count of 10
reads in at least one group of replicates. Differential ex-
pression was assessed using the generalized linear model
approach implemented in the Bioconductor package
DESeq2 [29]. Specifically, we used a call to the function
DESeq2, which: (a) provides an estimate of size factors
to normalize for sequencing depth, (b) estimates the dis-
persion function for the expression counts, and finally
(c) performs a fit with a negative binomial model that
uses the experimental groups as a single factor. Signifi-
cance of the differential expression was assessed using
the Wald test for the coefficients of the fitted model. De-
tails are described in the documentation of the Biocon-
ductor package DESeq2 [29]. The p-value was adjusted
to <0.01. Next, the “FDR”-method (False Discovery Rate;
FDR 10%, i.e. adjusted p-value <0.1) was computed using
the Benjamini-Hochberg algorithm and applied for cor-
rection of multiple testing. Differentially expressed genes
(DEG) were identified for the selected contrasts, i.e.,
pairwise comparisons. Complete results are provided in
Additional files 1, 2, 3 and 4. With these settings and the
expected variability of results, in particular following
antigestagen treatment, our approach was explorative
allowing us to select potential DEG for further down-
stream analysis by qPCR. Accordingly, the expression of
selected key target genes was validated by RT-PCR. As-
sociation of Gene Ontology (GO) categories with DEG
was computed using the Bioconductor package goseq
[30]. In order to detect significantly enriched biological
pathways, the RNA-Seq data were further analyzed with
Zatta et al. BMC Genomics  (2017) 18:757 Page 3 of 18
the web-based software QIAGEN’s Ingenuity(R) Pathway
Analysis (IPA(R), QIAGEN Redwood City, build version:
364,062 M, content version: 26,127,183 (release date:
2015-11-30)). Additionally, Partek(R) Genomics Suite(R)
(version 6.6 Copyright(C); 2015 Partek Inc., St. Louis,
MO, USA), a next generation sequencing, microarray
and qPCR data analysis software, and Enrichr, an inte-
grative web-based and mobile software application [31],
were applied to support and corroborate the results.
With the open source bioinformatics software platform
Cytoscape v3.0.0 [32] application ClueGO v2.2.3 [33],
analysis and visualization of possible differentially
enriched functional biological networks were performed
for the following contrasts (i.e., pairwise group compari-
sons): “luteal regression over luteolysis”, and “luteolysis
over antigestagen”. As input for IPA and Cytoscape, all
DEG with p < 0.01, FDR < 0.1 for the respective con-
trasts were used (Table 2, respective Additional files 1, 2,
3 and 4). The Venn diagrams show the overlap of DEG
when applying an additional fold-change threshold of
two-fold up- and down-regulation.
Expression of selected target genes by semi-quantitative
real time (TaqMan) polymerase chain reaction (PCR)
Total RNA from all samples was used for semi-
quantitative RT-PCR. With each sample, 10 ng of RNA
was used. DNase treatment was performed following the
instructions of the manufacturer (Promega, Dübendorf,
Switzerland) with RQ1 RNase-free DNase. Reverse tran-
scription (RT) was carried out with the supplier’s proto-
col for the High Capacity cDNA Reverse Transcription
Kit including RNase Inhibitor (Applied Biosystems from
Thermo Fisher Scientific, Foster City, CA, USA). The
quantity of cDNA was then increased by amplifying it
according to the protocol for the TaqMan® PreAmp
Master Mix Kit (Applied Biosystems).
TaqMan PCR was performed as described previously
[10, 34, 35]. Gene-specific primers and 6-
carboxyfluorescein (6-FAM) and 6-carboxytetramethyl-
rhodamine (TAMRA) labeled probes were designed
using PrimerExpress software version 2.0 (Applied Bio-
systems) ordered from Microsynth, Balgach, Switzerland.
The efficiency of self-designed expression assays was val-
idated as previously described [35] ensuring approxi-
mately 100%. The predesigned TaqMan systems were
ordered from Applied Biosystems by Thermo Fisher Sci-
entific. For an overview of the primers, TaqMan probes
and predesigned TaqMan systems see Table 1. Reactions
were run in an automated fluorometer ABI PRISM® 7500
Sequence Detection System (Applied Biosystems). As a
control, experiments were run in the absence of the en-
zyme during the reverse transcription step (the so-called
minus-RT control). Relative quantification was done
using the comparative CT method (ΔΔ CT method) [34,
35]. GAPDH, B-ACTIN and Cyclophilin A (PPIA) acted
as reference genes for normalization of target gene ex-
pression [34, 35]. The sample with the lowest expression
of the target gene served as the calibrator. Relative gene
expression (RGE) is presented. The threshold cycle (CT)
value constitutes the PCR cycle number at which the re-
ported fluorescence exceeds the base line above the
background fluorescence. Due to the uneven distribution
of Real Time data, logarithmic transformation was per-
formed and the results are presented as geometric
means (Xg) +/− geometric standard deviation (SD). An
unpaired, two-tailed Student’s t-test was applied to show
pairwise contrasts of gene expression between groups.
GraphPad3 (GraphPad Software Inc., San Diego, CA,
USA) was used; p < 0.05 was considered as significant.
Results
Analysis of RNA-Seq data
Pairwise comparisons (contrasts) of NGS data were per-
formed for selected experimental groups. The normal-
ized read count data were produced with the
Bioconductor package DEseq2 [29]. A summary of the
results for all contrasts investigated in the study is pre-
sented in Table 2. The complete result tables are avail-
able as Additional files 1, 2, 3 and 4.
Contrast: “luteal regression over luteolysis”.
The number of features with counts above threshold
of 10 reads per gene was 14,883. We call differentially
expressed genes (DEG) by applying a p-value threshold
of 0.01 and adjusted p-value (FDR) of 0.1 and found
1595 significant DEG: 1054 genes show lower and 541
show higher expression in the luteal regression group
compared to the luteolysis group.
Contrast: “mid-gestation over luteolysis”.
In this contrast, the number of features with counts
above the threshold 10 reads per gene was 14,469. Of
the 1745 DEG (p-value < 0.01, and adjusted p-value,
FDR < 0.1) found in this contrast, 690 were more highly
expressed and 1055 were lower at mid-gestation com-
pared to the luteolysis group.
Contrast: “mid-gestation over antigestagen”.
The number of features with counts above the thresh-
old of 10 reads per gene was 14,186. This contrast gen-
erated the highest variability in gene expression levels
and the least number of genes that were differentially
expressed. Of the 429 genes initially selected based on
the p < 0.01 criterion, only 92 DEG passed the FDR < 0.1
correction and were therefore used for all downstream
analyses; 38 genes were more and 54 genes were less
expressed in mid-gestation compared to the antigestagen
group. Although expected, the high variability of gene
expression limits the interpretability of results.
Contrast: “luteolysis over antigestagen”.
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For this contrast, the number of features with counts
above the threshold was 14,280. From the 1480 DEG
(p < 0.01, FDR < 0.1) identified in this contrast, 687 were
more and 793 were less expressed in the antigestagen
group in contrast to the luteolysis group.
Functional annotations and pairwise comparisons
We identified the Gene Ontology (GO) terms that are
enriched with differentially expressed genes in the three
subgroups: biological process (BP), cellular compartment
(CC) and molecular function (MF). Figs. 1 and 2 show
heatmaps of the differentially expressed genes together
with associated main functional terms. Lists of represen-
tative genes involved in particular GO terms in each
contrast are presented in Additional file 5.
“Luteal regression over luteolysis”:
GO terms having highly significant association with
genes upregulated in the luteal regression group are:
extracellular matrix (p = 5.52e-05) and matrix
organization (p = 0.001), steroid hormone mediated
Table 2 Summary of the RNA-Seq results for all contrasts investigated in the study, feature counts including DEG (differentially
expressed genes) numbers, are presented
Analysis Luteal regression over
luteolysis
Mid-gestation over
luteolysis
Mid-gestation over
antigestagen
Luteolysis over
antigestagen
Genes Total (p-value <0.01, FDR <0.1) 1595 1745 92 1480
Genes UP 541 690 38 793
Genes Down 1054 1055 54 687
Number of features 23,630 23,630 23,630 23,630
Number of features with counts above
threshold
14,883 14,469 14,186 14,280
Linear signal threshold 10 10 10 10
Table 1 List of primers used for Real Time (TaqMan) PCR
Primer Accession number Primer sequence Product length (bp)
SAA-for
SAA-rev
SAA-TaqMan Probe
NM_001313872.1 5′-TGG GAC ATG TTG AGA GCC TAC TC-3′
5′-CCT CTG TGC AGC GTC ATA GTT C-3′
5′-TTC AGA CAA ATA CTT CCA TGC CCG GG-3’
114
CXCL8-for
CXCL8-rev
CXCL8-TaqMan Probe
NM_001003200.1 5’-CCA CAC CTT TCC ATC CCA AA-3′
5′-CCA GGC ACA CCT CAT TTC CA-3′
5′-CTG AGA GTG ATT GAC AGT GGC CCA CAT TGT-3’
114
IL1b-for
IL1b-rev
IL1b-TaqMan Probe
NM_001037971.1 5’-TGC CAA GAC CTG AAC CAC AGT-3′
5′-CTG ACA CGA AAT GCC TCA GAC T-3′
5′-CAT CCA GTT GCA AGT CTC CCA CCA GC-3’
97
GAPDH-for
GAPDH-rev
GAPDH-TaqMan Probe
NM_001003142.2 5’-GCT GCC AAA TAT GAC GAC ATC A-3′
5′-GTA GCC CAG GAT GCC TTT GAG-3′
5′-TCC CTC CGA TGC CTG CTT CAC TAC CTT-3’
75
MHCII-for
MHCII-rev
MHCII-TaqMan Probe
NM_001011723.1 5’-GGA GAG CCC AAC ATC CTC ATC-3′
5′-GGT GAC AGG GTT TCC ATT TCG-3′
5′-TCG ACA AGT TCT CCC CAC C-3’
90
RXFP1-for
RXFP1-rev
RXFP1-TaqMan Probe
XM_014119744.1 5’-GGC ACC AAT GGA GTG TGT TTC-3′
5′-TGC CGC CAA GTT AAC ACC AA-3′
5′-TAC TGG AGC CCA GAT TTA TTC GGT GGC-3’
102
GATA 4 NM_001048112.1 Applied Biosystems, prod. nr.: Cf02736086_m1 104
JUN XM_860558.1 Applied Biosystems, prod. nr.: Cf02696722_g1 90
CCL13 NM_001003966.1 Applied Biosystems, prod. nr.: Cf02622470_mH 117
CCL3 NM_001005251.1 Applied Biosystems, prod. nr.: Cf02671956_m1 131
YY1 XM_849421.1 Applied Biosystems, prod. nr.: Cf02637858_m1 81
ECM2 XM_533562.2 Applied Biosystems, prod. nr.: Cf02641132_m1 74
GATA6 XM_547642.2 Applied Biosystems, prod. nr.: Cf02654912_m1 71
CCNA2 XM_540965.2 Applied Biosystems, prod. nr.: Cf02648449_g1 77
B-ACTIN NM_001003349.1 Applied Biosystems, prod. nr.: Cf03034055_u1 121
PPIA XM_843327.1 Applied Biosystems, prod. nr.: Cf03986523_gH 92
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signaling (p = 2.29e-04) and steroid hormone receptor activ-
ity (p = 1.63e-04), regulation of gene expression (p = 7.40e-
04), negative regulation of transcription from RNA polymer-
ase II promoter (p = 5.02e-05), and regulation of transcrip-
tion, DNA-templated (p = 2.45e-04), as well as positive
regulation of epithelial cell proliferation (p = 3.4e-03).
Terms associated with genes that were more highly
expressed in prepartum luteolysis were: immune re-
sponse (p = 1.35e-14) (e.g., leucocyte migration, chemo-
taxis) and inflammatory response (p = 2.87e-07),
regulation of response to wounding (p = 1.41e-05), re-
sponse to reactive oxygen species (p = 0.002), acute-
Fig. 1 Representative heatmaps showing the RNA-Seq analysis of differentially expressed genes (DEG) of two contrasts: a “luteal regression over
luteolysis”, and b “mid-gestation over luteolysis”. For each gene the red color indicates high expression relative to the average expression of the
gene, while the blue color indicates low expression. a 1595 DEG were detected for the contrast “luteal regression over luteolysis”, 1054 genes
were less and 541 were more highly expressed in luteal regression (p < 0.01, FDR < 0.1), b 1745 DEG were found in the contrast “mid-gestation
over luteolysis”, 1055 were less and 690 were more expressed in mid-gestation (P < 0.01, FDR < 0.1). The main functional terms overrepresented
in each of the groups are listed (details, including statistics are presented in the text). The entire list of DEG identified genes is provided as
Additional files 1 and 2
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phase response (p = 4.10e-06), positive regulation of
angiogenesis (p = 0.003), and apoptotic mitochondrial
changes (p = 0.02).
“Mid-gestation over luteolysis”:
More represented during mid-gestation were terms relat-
ing to extracellular matrix organization (p = 0.002), ana-
tomical structure regression (p = 0.01), angiogenesis
(p = 0.03) and TGFβ signaling pathway (p = 4.47e-06). In
contrast, represented more highly during prepartum
luteolysis were: immune (p = 5.34e-08) and inflammatory
response (p = 1.23e-04) (e.g., regulation of lymphocyte mi-
gration, positive regulation of defense response,
chemokine-mediated signaling, cytokine activity, leukocyte
cell-cell adhesion), acute-phase response (p = 0.003) and
extrinsic apoptotic signaling pathway (p = 0.02).
“Mid-gestation over antigestagen”:
In this contrast, functional terms enriched in mid-
gestation referred in general to: centrosome organization
Fig. 2 Representative heatmaps showing the RNA-Seq analysis of differentially expressed genes (DEG) of two contrasts: a “mid-gestation over
antigestagen”, and b “luteolysis over antigestagen”, are presented. For each gene the red color indicates high expression relative to the average
expression of the gene, while the blue color indicates low expression. a 492 genes were found for the contrast “mid-gestation over antigestagen”
based on the p < 0.01 threshold (shown). Of these, 92 DEG passed the FDR < 0.1 selection (adjusted p-value), of which 38 genes were more and
54 genes were less expressed at mid-gestation. These genes were used for further downstream analyses. b 1480 DEG were identified in the
contrast “luteolysis over antigestagen”, 793 were more and 687 were less expressed in the antigestagen group compared to the luteolysis group
(p < 0.01, FDR < 0.1). The main functional terms overrepresented in each of the groups are listed (details, including statistics are presented in the
text). The entire list of DEG identified genes is provided as Additional files 3 and 4
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(p = 0.002), regulation of mitotic metaphase/anaphase
transition (p = 7.34e-05), the oxidation-reduction
process (p = 0.002), steroid metabolic processes
(p = 1.38e-03) or protein ubiquitination (p = 0.006). The
antigestagen-treated group included enriched GO terms
such as: inflammatory response (p = 0.005), response to
IL1 (p = 7.29e-05) and RNA polymerase regulatory re-
gion sequence-specific DNA binding (p = 0.004).
“Luteolysis over antigestagen”:
This contrast revealed the presence of the following
main terms represented more during active prepartum
luteolysis: cellular response to TGFβ stimulus
(p = 3.00e-04), functional terms related to immune re-
sponse (p = 7.02e-04), and chemokine activity
(p = 4.68e-05), acute-phase response (p = 0.009) and
progesterone metabolic process (p = 0.01). The terms
that were represented more in the antigestagen-treated
group (i.e., during induced abortion/luteolysis) related to
negative regulation of cell proliferation (p = 2.04e-04)
and negative regulation of gene expression (p = 0.002).
Venn diagrams
We illustrated the intersections among genes differen-
tially expressed between the following selected contrasts:
“luteal regression over luteolysis” vs. “mid-gestation over
antigestagen” (Fig. 3), and “luteolysis over antigestagen”
vs. “mid-gestation over antigestagen” (Fig. 4). All genes
derived from the respective lists of DEG were used as in-
put (Additional files 1, 3 and 4). For the first compari-
son, 11 genes fulfilling the criteria (DEG p < 0.01,
FDR < 0.1 regardless of log2 ratio) were found overlap-
ping in both contrasts, 1584 genes were found solely in
the contrast “luteal regression over luteolysis” and 81
genes in the contrast “mid-gestation over antigestagen”
(Fig. 3). When genes upregulated in each gene set were
taken into consideration, additionally using the criteria
log2 ratio > 1, 2 genes (CYP17A1, SULT1E1) that were
commonly overrepresented overlapped in both con-
trasts, meaning that the same two upregulated genes can
be found in both contrasts. On the other hand, setting
the log2 ratio < −1, 5 commonly downregulated DEG
were identified in both contrasts (ZSWIM4, C5AR2,
TTC9, ADM5, C10orf10). Regarding the Venn diagrams,
which visualize comparison of the two contrasts “luteo-
lysis over antigestagen” vs. “mid-gestation over antigesta-
gen” (Fig. 4), 36 DEG (p < 0.01, FDR < 0.1 regardless of
log2 ratio) occurred in both contrasts. For log2 ratio > 1,
4 upregulated genes (CYP17A1, HJURP, AOC1, NT5E)
were found in both contrasts, and with log2 ratio < −1,
17 commonly downregulated genes were identified (e.g.,
FZD5, TMEM65, CSRNP3, RASEF, TRPC4, CLCN1,
C10orf10, NFIL3, KIF5C, ELL2). Detailed lists of over-
lapping genes are presented in Additional file 6.
Cytoscape analysis of functional networks
We used Cytoscape to visualize the correlation of func-
tional networks associated with differentially expressed
genes. We present the results for two contrasts: “luteal
regression over luteolysis” and “luteolysis over antigesta-
gen” in order to determine pathways potentially involved
in normal and induced parturition (Figs. 5 and 6). As in-
put, all DEG found for the respective contrasts were
used (Table 2, Additional files 1 and 4; threshold
p < 0.01, FDR < 0.1). Lists of representative genes
involved in particular networks are presented in
Additional file 5.
As for the contrast “luteal regression over luteolysis”
(Fig. 5), among the predominant functional networks
represented more in the luteal regression group were
those networks referring to matrix remodeling (up to 10
representative genes are shown in alphabetical order),
e.g., epithelial tube morphogenesis, connective tissue de-
velopment, steroid hormone signaling pathways and
Fig. 3 Venn diagram showing the intersection of differentially expressed
genes (DEG) in the contrast “luteal regression over luteolysis” compared
with the contrast “mid-gestation over antigestagen”. Lists of DEG
(p < 0.01, FDR < 0.1) presented in Additional files 1 and 3 were used.
Three analyses are presented: with up- and down-regulated genes
(regardless of log2 ratio), or with upregulated genes (log2 > 1), or with
downregulated genes (log2 < −1). When full sets of genes were used
(up and down regulated), 11 genes were found overlapping in both
contrasts, 1584 genes were found only in the contrast “luteal
regression over luteolysis” and 81 genes were found in “mid-
gestation over antigestagen”. Adding log2 ratio > 1 to the threshold,
2 over-represented genes overlapped in both contrasts, and for log2
ratio < −1, 5 downregulated genes were found
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cellular responses to steroidogenic stimulus, as well as
cAMP-mediated signaling. On the other hand, the vast
majority of more highly represented functional networks
detected during prepartum luteolysis were those related
to the immune system, e.g., regulation of the immune
response, response to cytokines, leukocyte activation,
lymphocyte activation, inflammatory response, and regu-
lation of apoptotic signaling pathways.
Regarding the next contrast “antigestagen over luteoly-
sis” (Fig. 6), the major functional network overrepre-
sented in the antigestagen-treated group related to the
negative regulation of transcription, e.g., negative regula-
tion of transcription from RNA polymerase II promoter,
negative regulation of cell proliferation, and networks re-
lating to the response to TGFβ. The functional networks
predominantly detected during active prepartum luteoly-
sis in this contrast included the response to wounding,
defense response and positive regulation of cellular
processes. Other strongly represented networks include
cytoskeleton organization and actin cytoskeleton
organization, as well as functional networks relating to
apoptotic signaling and regulation of cell death.
Ingenuity pathway analysis (IPA)
Lists of significant genes (DEG p < 0.01, FDR < 0.1 ) of
interest were uploaded into IPA software. Lists of repre-
sentative pathways, genes and top upstream regulators
are presented in Additional file 5. For the contrast “lu-
teal regression over luteolysis”, among the top overrepre-
sented canonical pathways induced during prepartum
luteolysis were: granulocyte adhesion and diapedesis
(p = 2.4e-11), agranulocyte adhesion and diapedesis
(p = 9.13e-09) and integrin signaling (p = 1.12e-08). The
top upstream regulators, which were all defined as inhib-
ited during luteal regression, i.e., predicted to be induced
during luteolysis were: lipopolysaccharide (p = 5.45e-34),
TNF (p = 3.12e-29), TGFB1 (p = 9.68e-29), IFNG
(p = 2.86e-26) and β-estradiol (p = 2.66e-23).
Regarding the contrast “mid-gestation over luteolysis”,
one of the predominant top canonical pathways repre-
sented more in luteolysis was NFκB signaling (p = 2.09e-
09), and the top upstream inhibited regulators for mid-
gestation, i.e., induced during luteolysis, were: TGFB1
(p = 6.86e-39), TNF (p = 5.62e-31), β-estradiol
(p = 2.97e-28), lipopolysaccharide (p = 4.20e-26) and
IFNG (p = 2.44e-23).
Due to the low number of input genes, no enriched
canonical pathways were identified in the contrast “mid-
gestation over antigestagen”. The top upstream regula-
tors included, however, e.g., NUPR1 (p = 6.80e-06) or
SOD1 (p = 1.96e-04).
The top canonical pathways for the last contrast
“luteolysis over antigestagen” included: signaling by Rho
family GTPases (p = 1.17e-16) and integrin signaling
(p = 4.06e-06), which were more highly represented in
normal prepartum luteolysis. The top upstream regula-
tors which were activated during luteolysis were TGFB1
(p = 4.33e-32) and TNF (p = 1.64e-18).
Expression of genes by semi-quantitative (TaqMan) RT-PCR
The expression of selected candidate genes was investi-
gated by semi-quantitative (TaqMan) PCR using all
available tissue samples (Fig. 7). Thirteen target genes
were chosen that were predicted to be either upregu-
lated or downregulated in particular contrasts based on
the deep sequencing results. The functional groups
chosen for validation of transcriptomics data included
immune system, regulation of extracellular matrix and
factors involved in steroid synthesis, including some
transcriptional factors. Generally, a good correlation was
found between transcriptomics and qPCR data. Thus, in
the pairwise comparison “luteal regression over prepartum
Fig. 4 Venn diagram showing the intersection of differentially
expressed genes (DEG) in the contrast “luteolysis over antigestagen”
compared with the contrast “mid-gestation over antigestagen”. Lists
of DEG (p < 0.01, FDR < 0.1) presented in Additional files 3 and 4
were used. Three analyses are presented: with up- and down-
regulated genes (regardless of log2 ratio), or with upregulated genes
(log2 > 1), or with downregulated genes (log2 < −1). When full sets of
genes were used (up and down regulated), 36 genes were identified in
both contrasts, 1444 genes were found in “luteolysis over antigestagen”
only, and 56 genes in “mid-gestation over antigestagen”. Setting the
log2 ratio > 1, 4 genes commonly over-represented in both comparisons
were found, and with log2 ratio < −1, 17 commonly downregulated
genes were detected
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Fig. 5 Cytoscape analysis of GO for the contrast “luteal regression over luteolysis” is presented. The functional terms overrepresented in each of the
groups are shown. As input differentially expressed genes (DEG) were used (threshold was set at p < 0.01, FDR < 0.1). The redundant and non-informative
terms were removed, and the resulting network was manually rearranged. For each network the size of the node implies the number of genes, while the
color intensity denotes the level of enrichment (see legend to illustration). Functional networks, which were more highly represented in the luteal regres-
sion group (a), refer predominantly to matrix remodeling, to the steroid hormone signaling pathway and to cAMP-mediated signaling. Networks more
highly represented during prepartum luteolysis (b) were associated to immune system, inflammatory response and regulation of apoptotic signaling
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luteolysis”, upregulated expression of ECM2, GATA4, GATA6
and RXFP1 was found in samples derived from luteal regres-
sion, compared with natural prepartum luteolysis (for details,
including statistical results, see Fig. 7a). On the other hand,
the expression of immune and proinflammatory factors:
MHCII, CXCL8 (IL8), IL1b, CCL3, CCL13 and SAA, was sig-
nificantly higher during prepartum luteolysis (Fig. 7a).
When comparing the two groups “mid-gestation over
luteolysis” (Fig. 7b), higher levels of JUN were detected
in mid-pregnant dogs. The expression of IL1b, CCL3,
MHCII and CCL13 was higher in samples collected dur-
ing prepartum luteolysis. The expression of steroido-
genic factor GATA4, which was predicted to be
downregulated during prepartum luteolysis, did not dif-
fer between the two groups in qPCR.
As for the impact of antigestagen treatment on gene
expression in mid-pregnant dogs (i.e., contrast “mid-ges-
tation over antigestagen”; Fig. 7c), the expression of
Fig. 6 Cytoscape analysis of GO for the contrast “luteolysis over antigestagen” is presented. The functional terms overrepresented in each of the groups
are shown. As input differentially expressed genes (DEG) were used (threshold was set at p < 0.01, FDR < 0.1). The redundant and non-informative terms
were removed, and the resulting network was manually rearranged. For each network the size of the node implies the number of genes, while the color
intensity denotes the level of enrichment (see legend to illustration). a The more highly represented functional networks for the prepartum luteolysis group
include, e.g., response to wounding, defense response, positive regulation of cellular process, cytoskeleton organization and apoptotic signaling, as well as
cell death. b The functional networks more represented in the antigestagen-treated group refer, e.g., to the negative regulation of transcription and net-
works relating to response to TGFβ
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CCNA2, a factor involved in cell proliferation, was in-
vestigated and was more highly expressed (P < 0.0007)
in the mid-pregnant group. Additionally, the expression
of factors involved in steroidogenic and luteotropic ac-
tions, i.e., GATA4 and RXFP1, was examined and also
found to be more highly represented in the mid-
pregnant group. The same was found for the expression
of proinflammatory factor CCL3, which was expressed
more (p < 0.01) in samples from animals in which abor-
tion was induced (for details see Fig. 7c).
For the last contrast “luteolysis over antigestagen”,
higher expression of pro-inflammatory and acute phase
reaction factors was confirmed during prepartum luteo-
lysis (Fig. 7d). This concerns the expression of MHCII,
Fig. 7 Expression of selected target genes for each of the investigated contrasts, as determined by Real Time (TaqMan) PCR. a “luteal regression
over luteolysis” (t-test: blue = luteal regression > luteolysis; red = luteolysis > luteal regression), b “mid-gestation over luteolysis” (t-test:
blue = mid-gestation > luteolysis; red = luteolysis > mid-gestation; black = unchanged), c “mid-gestation over antigestagen-treatment” (t-test:
blue = mid-gestation > antigestagen; red = antigestagen > mid-gestation), and d “antigestagen-treatment over luteolysis” (t-test: red = luteolysis
> antigestagen; blue = antigestagen > luteolysis; black = unchanged). Due to the uneven distribution of data, logarithmic transformation was per-
formed and the results are presented as geometric means (Xg) + − geometric standard deviation (SD). An unpaired, two-tailed Student’s t-test
was applied; p < 0.05 was considered as statistically significant. RGE = relative gene expression
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CXCL8 (IL8), CCL3 and SAA. The expression of JUN
was higher in the antigestagen-treated group. However,
the mRNA levels of YY1 did not differ significantly be-
tween the two groups in qPCR.
Discussion
Whereas in the dog the CL are the only major source of
circulating P4 during pregnancy and in non-pregnant cy-
cles, it is striking that the molecular and endocrine mech-
anisms regulating its life span are not yet fully understood.
Because of similar P4 profiles these mechanisms must dif-
fer mostly during termination of luteal function. Conse-
quently, here, for the first time a comparative, new
generation sequencing analysis was performed to investi-
gate the transcriptome of canine CL during the cessation
of their function in pregnant and non-pregnant animals.
Additionally samples from pregnant dogs in which prepar-
tum luteolysis/abortion was induced at mid-gestation with
the antigestagen aglepristone, were included.
One of our main goals was to compare samples col-
lected during late luteal regression (day 65 after ovula-
tion) with those from active prepartum luteolysis. At
this point, it is important to emphasize that in the dog
the prepartum luteolysis (characterized by actively de-
creasing P4 concentrations) already begins 12-42 h be-
fore any clinical and/or behavioral (e.g., nest building)
signs of parturition become visible [36, 37]. Therefore,
as presented here, it is extremely important to capture
the right time point for collection of samples in order to
validate them as being derived from prepartum luteoly-
sis. Pairwise alignments were performed between the re-
spective experimental groups.
When compared with prepartum luteolysis, the slow
luteal regression in non-pregnant bitches was character-
ized by functional terms related to structural changes of
the tissue, e.g., remodeling and organization of extracel-
lular matrix. The steroid hormone-mediated signaling
and activities, as well as factors related to regulation of
gene expression, were also more highly represented in
regressing CL. Genes involved in modification of matrix
were represented, e.g., by PDGFRA (platelet-derived
growth factor receptor α) or ECM2 (extracellular matrix
protein 2). Interestingly, some of the nuclear steroido-
genic receptors were detected within the overrepre-
sented group of genes involved in structural changes in
regressing canine CL, e.g., AR (androgen receptor),
ESR1 (estrogen receptor 1, the gene encoding for estro-
gen receptor ERα) or NR3C1 (glucocorticoid receptor).
In view of the postulated supportive effects of estrogens
on luteal maintenance, based on circulating profiles of
E2 closely matching those of P4 in pregnant and non-
pregnant bitches, the diminishing effects of luteolysis on
the ESR1 (ERα) expression drew our attention. The
cAMP-mediated signaling was among the pathways
more strongly represented during luteal regression than
at prepartum luteolysis. The cAMP/PKA-related tran-
scriptional activities are well known as the major posi-
tive regulators of steroidogenesis [38]. Thus, it can be
concluded that the ongoing remodeling, morphogenesis
and connective tissue development processes found in
regressing canine CL are associated with higher func-
tional and steroidogenic activities, compared with active
prepartum luteolysis. This clearly can be seen in con-
junction with the slowly ongoing functional and mor-
phological changes associated with corpus albicans
formation as a result of ageing of the steroidogenic ap-
paratus and its replacement by matrix and connective
tissue components.
The expression of selected target genes more highly
represented in regressing canine CL was verified. Among
these was ECM2, which has been proved to promote
matrix assembly and cell adhesiveness [39]. We also ex-
amined the expression of RXFP1, a receptor for relaxin
(RLN) proven to be involved in the maintenance of
connective tissue extracellular matrix [40] and which
influences the control of collagen turnover [41]. Import-
antly, in some species like pigs and rodents, a luteotropic
function of intraluteally produced RLN has been implied
[42, 43]. GATA4 and GATA6, both GATA binding pro-
teins and transcriptional factors, are important for the
synthesis of luteal P4 [44]. They are known to activate
promoters of various steroidogenic genes, e.g., steroido-
genic acute regulatory (STAR) protein [45], cholesterol
side chain cleavage cytochrome P450 gene (CYP11A1)
[46] or 3beta-hydroxysteroid dehydrogenase (3betaHSD)
[47]. Another gene of possible functional importance
with higher expression in the luteal regression group
was SULT1E1 (sulfotransferase family 1E member 1 also
known as estrogen sulfotransferase/EST), a key enzyme
for catalyzing the sulfoconjugation of estrogens. This
leads to their inactivation by preventing them from
binding to their respective estrogen receptors, ERα/β
[48]. The increased expression of SULT1E1 during luteal
regression could thus be involved in the functional with-
drawal of local estrogen effects in the canine CL. An
additional role for this enzyme during the ongoing fatty
degeneration of regressing/luteolytic canine CL appears
plausible, as its involvement in positive regulation of adi-
pogenesis has been shown, e.g., in humans [49]. This hy-
pothesis, however, requires further verification.
A completely different picture regarding endocrine
regulatory events emerges when functional terms and
networks overrepresented during active prepartum
luteolysis are considered. The vast majority of genes
more highly represented in this group, compared with
luteal regression, are related to immune and inflamma-
tory response, including activation of leukocytes and
acute-phase response. Also terms related to negative
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regulation of steroidogenesis, degeneration of mitochon-
dria and apoptosis were found. The acute phase re-
sponse is an immediate reaction based on inflammation
due to various elicitors such as tissue injury, infection
and trauma [50]. SAA (serum amyloid A protein) is one
of the acute phase proteins. During inflammation, the
baseline concentrations of this protein can increase by
more than 1000-fold [51]. Here, the high abundance of
the respective transcript was positively verified during
active prepartum luteolysis in the dog by semi-
quantitative PCR. Cytokines that are synthesized during
an inflammatory process are the main stimulators of the
acute-phase protein production, for example IL1β, IL6,
TNFα, IFN-γ, TGFβ [52] and possibly IL8 [53]. The
functional pathways and top upstream regulators de-
tected by IPA software, as well as overrepresented net-
works detected by Cytoscape during luteolysis, indicate
induction of the luteal immune system at prepartum.
Thus, besides the already mentioned activation of IL6
and IL8 signaling, in addition the NFκB signaling path-
way and overrepresentation of the TNF and LPS systems
were found, as well as the induction of TGFβ pathway.
Interestingly, the TGFβ signaling was shown to possess
profibrotic and anti-angiogenic potential, contributing
thereby to structural and functional luteolysis in the bo-
vine CL [54, 55]. Among the selected genes investigated
in our study by semi-quantitative PCR and belonging to
the immune response were: CXCL8 (chemokine (C-X-C
motif ) ligand 8; IL-8), IL1B (interleukin 1 beta), MHCII
(major histocompatibility complex, class II), CCL3 (che-
mokine (C-C motif ) ligand 3) or CCL13 (chemokine (C-
C motif ) ligand 13). The proinflammatory cytokine IL-8
is synthesized predominantly by macrophages and neu-
trophils, which are recruited to the site of inflammation
[56]. It is known for its chemotactic activity directed to-
wards T cells [57]. CCL3 and CCL13 are both chemokine
ligands, whose main task is to act as chemoattractants to
draw active immune cells to the site of inflammation.
MHCII proteins, in turn, are located on antigen-
presenting cells and play important roles during initiation
of the immune response [58].
Cumulatively, it becomes apparent that active prepartum
luteolysis in the dog represents a highly inflammatory,
acute event, involving activation of multiple pathways re-
sponsible for the immune response. This reaction seems to
be triggered by concomitantly increasing utero-placental
PGF2alpha. It is noteworthy that, regarding potential in-
volvement of the immune system in the regulation of luteal
function during active prepartum luteolysis in the dog, our
results corroborate observations made previously in other
species, e.g. in rodents, humans or farm animals like sheep,
pigs, cattle and horses, as reviewed in [59].
The acute inflammatory nature of luteolysis also be-
comes obvious when comparing the mid-gestation group
with prepartum luteolysis. Whereas in mid-pregnant dogs
the remodelling processes associated with structural CL
regression were already clearly visible, also in this contrast
the prepartum luteolysis was characterized by inflamma-
tory- and acute-phase responses, including NFκB-, TNF-
and LPS- mediated effects, as well as by apoptotic signal-
ing. Similarly, the expression of selected target genes
(IL1b, CCL3, CCL13 and MHCII) was confirmed, display-
ing higher levels during natural luteolysis. TGFβ signaling
was represented both by genes relating to structural re-
modelling during mid-gestation (detected by Bioconduc-
tor), and to inflammatory pathways found by IPA software
during prepartum luteolysis. This further underlines its
possible involvement in morphological and functional ces-
sation of the canine CL life span.
Antigestagen treatment results in preterm luteolysis/
abortion [10, 25] and accelerates luteal regression in mid-
luteal, non-pregnant bitches [60]. The underlying molecu-
lar and endocrine mechanisms associated with the func-
tional withdrawal of P4 remain, however, not completely
understood. This prompted us to investigate the impact of
aglepristone on the luteal transcriptome in mid-pregnant
dogs, comparing them with non-treated controls. There-
fore, the experimental contrast “mid-gestation over anti-
gestagen” was established. However, this contrast resulted
in the highest variability of gene expression. Thus, despite
the relatively high number of genes, the expression of
which differed at the applied level of p < 0.01 (429 genes),
when the corrected p-value (FDR) of <0.1 was applied, the
list of DEG became restricted to 92 genes. This strongly
limited interpretation of these results. It appears, however,
that application of antigestagen to mid-pregnant dogs re-
sults in induction of the immune response and suppresses
terms related to proliferation and protein metabolism.
These effects were mirrored by higher expression of se-
lected target genes validated by semi-quantitative PCR.
Thus, the cyclin A2 (CCNA2), an important positive regu-
lator of cell cycle progression, was more highly expressed
in the CL of control mid-pregnant dogs. Interestingly,
however, although it was significantly enriched at the level
of p < 0.01, expression of this gene did not pass the ini-
tially applied FDR <0.1 selection criterion. Additionally,
we found increased expression of transcriptionally and
steroidogenically active GATA4 and RXFP1, during mid-
pregnancy. On the other hand, the immune system-
derived CCL3 was elevated in treated CL. Cumulatively,
based on the results presented herein, and despite the high
variability of results obtained in the discussed contrast
(i.e., mid-gestation over antigestagen), the luteotropic
function of P4 within canine CL may be related to positive
regulation of the cell cycle, proliferation and transcrip-
tional activity, and anti-inflammatory effects.
Interestingly, as revealed in the next comparison, al-
though it led to suppression of luteal steroidogenesis,
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when compared with the natural prepartum luteolysis,
the antigestagen treatment evoked weaker immune and
inflammatory reactions. Instead, as in the previous
contrast, the inhibitory effects related predominantly to
cell proliferation, also inhibition of transcription and
gene expression was prevalent. Additionally, Cytoscape
assigned genes associated with functional networks relat-
ing to the response to TGFβ in the antigestagen-treated
group. Among these were genes associated with struc-
tural remodelling of tissue such as ADAMTSL2. Among
representative genes expressed more during natural
luteolysis and positively validated by semi-quantitative
PCR were immunoreactive factors involved in the acute
response, such as CXCL8 (IL8) and SAA. Besides the
acute inhibition of P4 production during natural luteoly-
sis, the functional withdrawal of P4 during this time was
marked by higher expression of transcripts encoding for
CYP17A1 (steroid-17alpha-hydroxylase) enzyme. Acting
upon P4, CYP17A1 catalyzes its conversion to the less
biologically potent 17-OHP (17-hydroxyprogesterone).
Changes induced in luteal transcriptomes, commonly
regulated during normal and induced luteolysis, were com-
pared using Venn diagrams. First, we aimed to compare the
changes induced by endogenous PGF2alpha in late regres-
sing CL (i.e., during natural luteolysis), with the
antigestagen-mediated changes evoked in fully active CL.
Therefore, the two contrasts “luteal regression over luteoly-
sis” and “mid-gestation over antigestagen” were chosen. We
found two genes, CYP17A1 and SULT1E1, which were
commonly represented more during luteal regression and
mid-gestation over their luteolytic counterparts. Thus, both
genes that were less expressed in CL dominated by apop-
tosis are involved in controlling luteal steroidogenic cap-
ability. Genes which were commonly more highly
expressed in luteolytic groups included some of the im-
mune system-relevant factors like C5AR2 (CD88).
In the next comparison we were interested to find the
genes characteristic of antigestagen-mediated effects. The
two contrasts submitted to the analysis were: “luteolysis
over antigestagen” and “mid-gestation over antigestagen”.
We found CYP17A, being commonly less expressed in
antigestagen-treated samples in both contrasts. Among
genes commonly more represented in the antigestagen
groups of this contrast were CSRNP3 (known as TGF-β-
induced apoptosis protein 2) and ELL2 (elongation factor
for RNA polymerase II 2), a regulator of gene transcription.
Conclusions
Herein, deeper insights have been obtained into possible
cellular mechanisms governing the luteal life span in the
domestic dog during pregnancy and in non-pregnant cy-
cles. The most important conclusions from our study
are summarized in Fig. 8.
Clearly, the data obtained by RNA-Seq are not definitive,
as they need to be further substantiated by studies involving
Fig. 8 A cumulative presentation of major conclusions drawn from the present study is shown. Thus, luteal regression in non-pregnant bitches
appears to be a slowly ongoing, passive degenerative process leading to corpus albicans formation, associated with structural remodelling
processes in the absence of an acute inflammatory reaction. The latter, i.e., acute inflammation, is observed during prepartum luteolysis,
and is most probably caused by PGF2alpha of utero-placental origin. The antigestagen-mediated effects seem to relate primarily to inhibition of the
luteotropic function of progesterone (P4), rather than to the inflammatory reaction evoked by its withdrawal
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larger numbers of animals and by presenting more mech-
anistic approaches, including in vivo and in vitro studies.
Nevertheless, however, the analysis of transcriptomes
presented herein supports our previously postulated hy-
pothesis describing luteal regression in non-pregnant dogs
as a degenerative process devoid of the acute luteolytic
principle and without acute involvement of the immune
system as observed prepartum [1]. The contribution of
the immune system seems to be critical in the PGF2alpha-
mediated active prepartum luteolysis, which appears to be
an acute immune process. The antigestagen-mediated ef-
fects may primarily result in the inhibition of gene expres-
sion and cell proliferation, as well as the inflammatory
response. These effects cumulatively point towards the
withdrawal of the luteotropic function of P4.
The P4-mediated effects can be especially important
for understanding some of the clinical conditions associ-
ated with the negative pregnancy outcomes, such as lu-
teal insufficiency which affects some bitches.
Finally, several differentially expressed genes were
identified within the experimental groups representing
different functional pathways and networks and being
possibly involved in the maintenance and cessation of
canine luteal function. Some of them deserve closer at-
tention for determining future research directions, like
the TGFβ-mediated pathways. Similarly, the cellular ori-
gin and functional interplay between different immune
system-derived factors need further clarification. Future
studies will also need to focus on translating information
obtained from investigating the transcriptome to func-
tional studies at the protein level.
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